(Q53436066)

14 May 2018

title

PET imaging with hypoxia tracers: a must in radiation therapy. (English)

1 reference

14 May 2018

adaptive radiation therapy

main subject

0 references

0 references

1

1 reference

14 May 2018

publication date

1 April 2008

1 reference

14 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

14 May 2018

volume

35

1 reference

14 May 2018

issue

4

1 reference

14 May 2018

page(s)

838-842

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-008-0740-2

exact match

0 references

cites work

Hypoxia in cancer: significance and impact on clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Imaging oxygenation of human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0740-2

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

21 January 2018

1 reference

12 December 2020

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

1 reference

12 December 2020

PET and PET/CT studies of tumor tissue oxygenation.

1 reference

12 December 2020

Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix

1 reference

12 December 2020

10.1007/S00259-008-0740-2

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018